Takeda Pharmaceutical's $62 billion purchase of Shire is completed, and the combined company is poised to become one of the world's top 10 drugmakers. The deal will also expand the Japanese company's presence in the US.
Takeda completes $62B purchase of Shire
Sign up for AABB SmartBrief
News about transfusion and cellular therapies
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.